Market Research Logo

North America Cancer Biomarker Market Forecast 2017-2025

North America Cancer Biomarker Market Forecast 2017-2025KEY FINDINGS

The United States is a primary contributor to the North American cancer biomarker market, which is all set to expand with a CAGR of 13.17% between the forecasted years of 2017-2025. The market collections are also predicted to increase from $3748 million in 2016 to $11420 million by 2025.

MARKET INSIGHTS

The market is mainly segmented into two segments: discovery& diagnostics and diseases. These two are further divided into multiple sub-segments. The huge investments from private funds and government institutions for cancer research, improvement in the precision and speed of diagnosis and the rising production of highly specific drugs are majorly responsible for the surge in the North American region. However, the rigorous regulatory agenda and a dearth of skilled workers are the growing concerns faced by this market.

COMPETITIVE INSIGHTS

Diadexus Inc (Acquired By Diazyme Laboratories), Qiagen N.V, Affymetrix, Inc (Acquired By Thermofisher), Abbott Laboratories, Agilent Technologies Aureon Biosciences Inc, Roche Diagnostics Ltd and, Illumina Inc are few of the important market players in the region.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
2.5. Estimation Methodology
3. Executive Summary
3.1. Key Findings
4. Market Determinants
4.1. Market Drivers
4.1.1. Adoption Of Western Lifestyles In Developing Regions
4.1.2. Growing Prevalence On Research Of Cancer Biomarkers
4.1.3. Encouragement For Biomarker Development By Fda
4.1.4. Improved Precision And Speed Of Diagnosis
4.1.5. High Investment Through Government And Private Funds In Cancer Related Research
4.1.6. Development Of Highly Specific Drugs
4.2. Restraints
4.2.1. Poor Compensation Structures
4.2.2. Low Estimated Rate Of Successful Clinical Trials Of Biomarkers
4.2.3. Technical Issues Related To Cancer Biomarkers
4.3. Market Opportunities
4.3.1. Wide Opportunity To Grow In Personalized Medication
4.3.2. Supports On Biomarkers Test
4.3.3. Growing Number Of Cancer Patients And Growing Medical Tourism In Emerging Economies
4.4. Market Challenges
4.4.1. Lacking Acceptance Of The Cancer Biomarker
4.4.2. Unfavorable Compensation Situation
4.4.3. High Cost Of Developing Companion Diagnostics
4.4.4. Rigorous Regulatory Agenda
4.4.5. Dearth Of Skilful Workers
5. Market Segmentation
5.1. Market By Discovery And Diagnostics 2017-2025
5.1.1. Biomarker Discovery
5.1.1.1. Genetic Methods
5.1.1.1.1. Dna Arrays
5.1.1.1.2. Polymerase Chain Reaction (Pcr)
5.1.1.1.3. Reverse Transcriptase Polymerase Chain Reaction (Rt-pcr)
5.1.1.1.4. Fluorescent In Situ Hybridization (Fish)
5.1.1.1.5. Southern Blot
5.1.1.2. Imaging
5.1.1.2.1. Magnetic Resonance Imaging (Mri)
5.1.1.2.2. Computed Tomography (Ct)
5.1.1.2.3. Positron Emission Tomography (Pet)
5.1.1.2.4. Ultrasound
5.1.1.2.5. Single-photon Emission Computed Tomography (Spect)
5.1.1.2.6. X-ray
5.1.1.2.7. Magnetic Resonance Spectroscopy (Mrs)
5.1.1.2.8. Biophotonics
5.1.1.3. Protein Methods
5.1.1.3.1. Mass Spectrometry (Ms)
5.1.1.3.2. Immunohistochemistry (Ihc)
5.1.1.4. Metabolomics
5.1.2. Biomarker Diagnostic
5.1.2.1. Genetic And Genomic Markers
5.1.2.2. Proteomics
5.1.2.3. Dna Microarrays
5.1.2.4. Immunoassays
5.1.2.5. Immunohistochemical Tests
5.1.2.6. Pharmacogenomics
5.1.2.7. Molecular (Dna And Genomic) Diagnostic Assays
5.1.2.8. Flow Cytometry
5.1.2.9. Monoclonal Antibodies
5.1.2.10. Stem Cell Markers
5.1.2.11. Invitro Diagnostic Multivariate Index
5.2. Market By Disease 2017-2025
5.2.1. Lung Cancer
5.2.2. Breast Cancer
5.2.3. Colorectal Cancer
5.2.4. Prostate Cancer
5.2.5. Cervical Cancer
5.2.6. Other Cancer
6. Key Analytics
6.1. Porters Five Force Model
6.1.1. Threat Of New Entrants
6.1.2. Threat Of Substitute Product
6.1.3. Bargaining Power Of Buyer
6.1.4. Bargaining Power Of Suppliers
6.1.5. Intensity Of Competitive Rivalry
6.2. Opportunity Matrix
6.3. Key Buying Criteria
6.3.1. Pricing
6.3.2. Efficacy
6.3.3. Application And Effectiveness
6.4. Vendor Landscape
7. Geographic Analysis
7.1. North America
7.1.1. United States
7.1.2. Canada
8. Company Profiling
8.1. Competitive Landscape
8.1.1. Market Share Analysis
8.1.2. Top Winning Strategies
8.2. Abbott Laboratories
8.2.1. Overview
8.2.2. Product Portfolio
8.2.3. Scot Analysis
8.2.4. Strategic Initiatives
8.3. Affymetrix, Inc.(Acquired By Thermofisher)
8.3.1. Overview
8.3.2. Product Portfolio
8.3.3. Scot Analysis
8.3.4. Strategic Initiatives
8.4. Agendia N.V.
8.4.1. Overview
8.4.2. Product Portfolio
8.4.3. Scot Analysis
8.4.4. Strategic Initiatives
8.5. Agilent Technologies, Inc.
8.5.1. Overview
8.5.2. Product Portfolio
8.5.3. Scot Analysis
8.5.4. Strategic Initiatives
8.6. Astellas Pharma Inc.
8.6.1. Overview
8.6.2. Product Portfolio
8.6.3. Scot Analysis
8.6.4. Strategic Initiatives
8.7. Becton Dickinson And Company
8.7.1. Overview
8.7.2. Product Portfolio
8.7.3. Scot Analysis
8.7.4. Strategic Initiatives
8.8. Clarient, Inc. (Acquired By Neogenomics Laboratories)
8.8.1. Overview
8.8.2. Product Portfolio
8.8.3. Scot Analysis
8.8.4. Strategic Initiatives
8.9. Diadexus Inc. (Acquired By Diazyme Laboratories)
8.9.1. Overview
8.9.2. Product Portfolio
8.9.3. Scot Analysis
8.9.4. Strategic Initiatives
8.10. Illumina, Inc
8.10.1. Overview
8.10.2. Product Portfolio
8.10.3. Scot Analysis
8.10.4. Strategic Initiatives
8.11. Qiagen N.V. Overview
8.11.1. Product Portfolio
8.11.2. Scot Analysis
8.11.3. Strategic Initiatives
8.12. Roche Diagnostics Ltd
8.12.1. Overview
8.12.2. Product Portfolio
8.12.3. Scot Analysis
8.12.4. Strategic Initiatives
8.13. Ambrilia Biopharma Inc.
8.13.1. Overview
8.13.2. Product Portfolio
8.13.3. Scot Analysis
8.13.4. Strategic Initiatives
8.14. Aureon Biosciences, Inc
8.14.1. Beckman Coulter Overview
8.14.2. Product Portfolio
8.14.3. Scot Analysis
8.14.4. Strategic Initiatives
8.15. Biomoda Inc.
8.15.1. Overview
8.15.2. Product Portfolio
8.15.3. Scot Analysis
8.15.4. Strategic Initiatives
Table List
Table # 1 Recent Research On Biomarkers
Table # 2 List Of Fda Approved Protein Cancer Biomarkers (2015)
Table # 3 Potential Clinical Uses Of Cancer Biomarkers
Table # 4 Medical Tourism Prices In Us Dollar
Table # 5 North America Cancer Biomarker Market, By Discovery And Diagnostics 2017-2025 ($million)
Table # 6 North America Genetic Methods Market 2017-2025 ($million)
Table # 7 North America Genetic Methods Market, 2017-2025 ($million)
Table # 8 North America Dna Arrays Market, 2017-2025 ($million)
Table # 9 North America Polymerase Chain Reaction Market, 2017-2025 ($million)
Table # 10 North America Reverse Transcriptase Polymerase Chain Reaction Market, 2017-2025 ($million)
Table # 11 North America Fluorescent In Situ Hybridization Market, 2017-2025 ($million)
Table # 12 North America Southern Blot Market, 2017-2025 ($million)
Table # 13 North America Imaging Market 2017-2025 ($million)
Table # 14 North America Imaging Market, 2017-2025 ($million)
Table # 15 North America Magnetic Resonance Imaging Market, 2017-2025 ($million)
Table # 16 North America Computed Tomography Market, 2017-2025 ($million)
Table # 17 North America Positron Emission Tomography Market, 2017-2025 ($million)
Table # 18 North America Ultrasound Market, 2017-2025 ($million)
Table # 19 North America Single Photon Emission Computed Tomography Market, 2017-2025 ($million)
Table # 20 North America X-ray Market, 2017-2025 ($million)
Table # 21 North America Magnetic Resonance Spectroscopy Market, 2017-2025 ($million)
Table # 22 North America Biophotonics Market, 2017-2025 ($million)
Table # 23 North America Protein Methods Market 2017-2025 ($million)
Table # 24 North America Protein Methods Market, 2017-2025 ($million)
Table # 25 North America Mass Spectrometry Market,2017-2025 ($million)
Table # 26 North America Immunohistochemistry Market, 2017-2025 ($million)
Table # 27 North America Metabolomics Market, 2017-2025 ($million)
Table # 28 North America Biomarker Diagnostic Market, 2017-2025 ($million)
Table # 29 North America Genomics And Genetic Markers Market, 2017-2025 ($million)
Table # 30 North America Proteomics Market, 2017-2025 ($million)
Table # 31 North America Dna Microarrays Market, 2017-2025 ($million)
Table # 32 North America Immunoassays Market, 2017-2025 ($million)
Table # 33 North America Immunohistochemical Tests Market, 2017-2025 ($million)
Table # 34 North America Pharmacogenomics Market, 2017-2025 ($million)
Table # 35 North America Molecular (Dna And Genomic) Diagnostic Assays Market, 2017-2025 ($million)
Table # 36 North America Flow Cytometry Market, 2017-2025 ($million)
Table # 37 North America Monoclonal Antibodies Market, 2017-2025 ($million)
Table # 38 North America Stem Cell Markers Market, 2017-2025 ($million)
Table # 39 North America In Vitro Diagnostic Multivariate Index Assays Market, 2017-2025 ($million)
Table # 40 North America Cancer Biomarkers Market, By Disease 2017-2025 ($million)
Table # 41 North America Lung Cancer Market, 2017-2025 ($million)
Table # 42 North America Breastcancer Market, 2017-2025 ($million)
Table # 43 North America Colorectal Cancer Market, 2017-2025 ($million)
Table # 44 North America Prostate Cancer Market, 2017-2025 ($million)
Table # 45 Human Specimens For Cancer Biomarker Discovery
Table # 46 North America Cervical Cancer Market, 2017-2025 ($million)
Table # 47 Lists Of Fda-qualified Biomarkers
Table # 48 North America Other Cancer Market, 2017-2025 ($million)
Table # 49 Estimated New Cancer Cases And Deaths For 2017, By Sex
Table # 50 North America Cancer Biomarkers Market, 2017-2025($ Million)
Figure List
Figure # 1 Increasing Number Of People Living With Cancer Across The Globe For Period 2012-2020 (Million)
Figure # 2 Most Common Cancer Causing Deaths In 2015
Figure # 3 Pharmacogenomic Biomarkers Information In Drug Labeling
Figure # 4 Percentages Of Patients Ineffective For Particular Drug
Figure # 5 List Of Cleared Or Approved Companion Diagnostic Devices (Imaging Tools And In Vitro) By Fda
Figure # 6 North America Genetic Methods Market 2017-2025 ($million)
Figure # 7 North America Dna Arrays Market 2017-2025 ($million)
Figure # 8 North America Polymerase Chain Reaction Market 2017-2025 ($million)
Figure # 9 North America Reverse Transcriptase Polymerase Chain Reaction Market 2017-2025 ($million)
Figure # 10 North America Fluorescent In Situ Hybridization Market 2017-2025 ($million)
Figure # 11 North America Southern Blot Market 2017-2025 ($million)
Figure # 12 North America Imaging Market 2017-2025 ($million)
Figure # 13 North America Magnetic Resonance Imaging Market 2017-2025 ($million)
Figure # 14 North America Computed Tomography Market 2017-2025 ($million)
Figure # 15 North America Positron Emission Tomography Market 2017-2025 ($million)
Figure # 16 North America Ultrasound Market 2017-2025 ($million)
Figure # 17 North America Single Photon Emission Computed Tomography Market 2017-2025 ($million)
Figure # 18 North America X-ray Market 2017-2025 ($million)
Figure # 19 North America Magnetic Resonance Spectroscopy Market 2017-2025 ($million)
Figure # 20 North America Biophotonics Market 2017-2025 ($million)
Figure # 21 North America Protein Methods Market 2017-2025 ($million)
Figure # 22 North America Mass Spectrometry Market 2017-2025 ($million)
Figure # 23 North America Immunohistochemistry Market 2017-2025 ($million)
Figure # 24 North America Metabolomics Market 2017-2025 ($million)
Figure # 25 North America Genomics And Genetic Markers Market 2017-2025 ($million)
Figure # 26 North America Proteomics Market 2017-2025 ($million)
Figure # 27 North America Dna Microarrays Market 2017-2025 ($million)
Figure # 28 North America Immunoassays Market 2017-2025 ($million)
Figure # 29 North America Immunohistochemical Tests Market 2017-2025 ($million)
Figure # 30 North America Pharmacogenomics Market 2017-2025 ($million)
Figure # 31 North America Molecular (Dna And Genomic) Diagnostic Assays Market 2017-2025 ($million)
Figure # 32 North America Flow Cytometry Market 2017-2025 ($million)
Figure # 33 North America Monoclonal Antibodies Market 2017-2025 ($million)
Figure # 34 North America Stem Cell Markers Market 2017-2025 ($million)
Figure # 35 North America In Vitro Diagnostic Multivariate Index Assays Market 2017-2025 ($million)
Figure # 36 North America Lung Cancer Market, 2017-2025 ($million)
Figure # 37 New Cases Of Lung & Bronchus Cancer And Associated Deaths, 2015
Figure # 38 North America Breastcancer Market 2017-2025 ($million)
Figure # 39 North America Colorectal Cancer Market 2017-2025 ($million)
Figure # 40 Statistics Of Colorectal Cancer In 2016
Figure # 41 North America Prostate Cancer Market 2017-2025 ($million)
Figure # 42 North America Cervical Cancer Market 2017-2025 ($million)
Figure # 43 North America Other Cancer Market 2017-2025 ($million)
Figure # 44 United States Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 45 Canada Cancer Biomarkers Market 2017-2025 ($ Million)
Figure # 46 Market Share Analyses Of Key Players 2016 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report